Sanofi-Aventis to invest in R&D in Spain
Business Investments
01 Apr 2012
France-based pharmaceutical company Sanofi-aventis plans to invest $1.3 million in research and development (R&D) projects of Barcelona's international biomedical research institute CRG.
The projects include cell reprogramming, the application of synthetic biology technology to treat lung diseases, the influence of genes as factor for some diseases and tuberculosis treatment, the director of CRG, Luis Serrano, said.
Source: IPA WORLD, 8/3/2012
Related news and success stories.
-
25 Mar 2024
See more French company K·Line invests 18 million euros in a new factory in CataloniaFrench company K·Line invests 18 million euros in a new factory in Catalonia
-
20 Mar 2024
See more Boehringer Ingelheim, commited to Catalonia's Life Sciences talentBoehringer Ingelheim, commited to Catalonia's Life Sciences talent
-
15 Mar 2024
See more AstraZeneca invests 1.3 billion euros in its R&D center in Barcelona, doubling its job creation forecast to 2,000AstraZeneca invests 1.3 billion euros in its R&D center in Barcelona, doubling its job creation forecast to 2,000
-
08 Mar 2024
See more UK company Startup Sherpas opens a new office in BarcelonaUK company Startup Sherpas opens a new office in Barcelona
